Lanthionine synthetase components C-like 2 increases cellular sensitivity to adriamycin by decreasing the expression of P-glycoprotein through a transcription-mediated mechanism

Cancer Research

Volumn 63, Issue 3, 2003, Pages 723-727

  Park, Soyeon ^a   James, C David ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOPROTEIN P; LANTHIONINE; MULTIDRUG RESISTANCE PROTEIN 1; SYNTHETASE;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG SENSITIVITY; GENE; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LANCL2 GENE; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENES, MDR; HUMANS; MEMBRANE PROTEINS; NUCLEAR PROTEINS; P-GLYCOPROTEIN; SARCOMA; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 0037310181     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Schwab, M., Alitalo, K., Klempnauer, K. H., Varmus, H. E., Bishop, J. M., Gilbert, F., Brodeur, G., Goldstein, M., and Trent, J. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature (Lond.), 305: 245-248, 1983.
2. Khatib, Z. A., Matsushime, H., Valentine, M., Shapiro, D. N., Sherr, C. J., and Look, A. T. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res., 53: 5535-5541, 1993.
3. King, C. R., Kraus, M. H., and Aaronson, S. A. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science: (Wash. DC), 229: 974-976, 1985.
4. Schuuring, E., Verhoeven, E., Mooi, W. J., and Michalides, R. J. Identification and cloning of two overexpressed genes, U21B31/PRADI and EMSI, within the amplified chromosome 11q13 region in human carcinomas. Oncogene, 7: 355-361, 1992.
5. Tanigami, A., Tokino, T., Takita, K., Ueda, M., Kasumi, F., and Nakamura, Y. Detailed analysis of an amplified region at chromosome 11q13 in malignant tumors. Genomics. 13: 21-24, 1992.
6. Tomasetto, C., Regnier, C., Moog-Lutz, C., Mattei, M. G., Chenard, M., P., Lidereau, R., Basset, P., and Rio. M. C. Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17. Genomics, 28: 367-376, 1995.
7. Forus, A., Florenes, V. A., Maelandsmo, G. M., Meltzer, P. S., Fodstad, O., and Myklebost, O. Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2. Cell Growth Differ., 4: 1065-1070, 1993.
8. Amler. L. C., Schurmann, J., and Schwab. M. The DDXI gene maps within 400 kbp 5' to MYCN and is frequently coamplified in human neuroblastoma. Genes Chromosomes Cancer, 15: 134-137, 1996.
9. Smith, K., Houlbrook, S., Greenall, M., Carmichael, J., and Harris, A. L. Topoisomerase II alpha co-amplification with erbB2 in human primary breast cancer and breast cancer cell lines: relationship to m-AMSA and mitoxantrone sensitivity. Oncogene, 8: 933-938, 1993.
10. George, R. E., Kenyon, R., McGuckin, A. G., Kohl, N., Kogner, P., Christiansen, H., Pearson, A. D., and Lunec, J. Analysis of candidate gene co-amplification with MYCN in neuroblastoma. Eur. J. Cancer, 33: 2037-2042, 1997.
11. Jarvinen, T. A., Tanner, M., Rantanen, V., Barlund, M., Borg, A., Grenman, S., and Isola, J. Amplification and deletion of topoisomerase Il alpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer. Am. J. Pathol., 156: 839-847, 2000.
12. Coon, J. S., Marcus, E., Gupta-Burt, S., Seelig, S., Jacobson, K., Chen, S., Renta, V., Fronda, G., and Preisler, H. D. Amplification and overexpression of topoisomerase II alpha predict response to anthracycline-based therapy in locally advanced breast cancer. Clin. Cancer Res., 8: 1061-1067, 2002.
13. Wang, X. Y., Smith, D. I., Frederick, L., and James, C. D. Analysis of EGF receptor amplicons reveals amplification of multiple expressed sequences. Oncogene, 16: 191-195, 1998.
14. Eley, G. D., Reiter, J. L., Pandita, A., Park, S., Jenkins, R. B., Maihle, N. J., and James, C. D. A chronmsomal region 7p11.2 transcript map: its development and application to the study of EGFR amplicons in glioblastoma. Neuro-Oncology, 4: 86-94, 2002.
15. Mayer, H., Pongratz, M., and Prohaska, R. Molecular cloning, characterization, and tissue-specific expression of human LANCL2, a novel member of the LanC-like protein family. DNA Seq., 12: 161-166, 2001.
16. Musco, G., Stier, G., Joseph, C., Castiglione Morelli, M. A., Nilges, M., Gibson, T. J., and Pastore, A. Three-dimensional structure and stability of the KH domain: molecular insights into the fragile X syndrome. Cell, 85: 237-245, 1996.
17. Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., and Gottesman, M. M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev., Pharmacol. Toxicol., 39: 361-398, 1999.
18. Gosland, M. P., Lum, B. L., and Sikic, B. I. Reversal by cefoperazone of resistance to etoposide, doxorubicin, and vinblastine in multidrug resistant human sarcoma cells. Cancer Res., 49: 6901-6905, 1989.
19. Orth, J. D., Krueger, E. W., Cao, H., and McNiven, M. A. The large GTPase dynamin regulates actin comet formation and movement in living cells. Proc. Natl. Acad. Sci. USA, 99: 167-172, 2002.
20. Chuang, S. E., Doong, S. L., Lin, M. T., and Cheng, A. L. Tax of the human T-lymphotropic virus type I transactivates promoter of the MDR-1 gene. Biochem. Biophys. Res. Commun., 238: 482-486, 1997.
21. Jin, S., and Scotto, K. W. Transcriptional regulation of the MDRI gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol. Cell. Biol., 18: 4377-4384, 1998.
22. Deb, S. P., Munoz, R. M., Brown, D. R., Subler, M. A., and Deb, S. Wild-type human p53 activates the human epidermal growth factor receptor promoter. Oncogene, 9: 1341-1349, 1994.
23. Watabe, T., Yoshida, K., Shindoh, M., Kaya, M., Fujikawa, K., Sato, H., Seiki, M., Ishii, S., and Fujinaga, K. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int. J. Cancer, 77: 128-137, 1998.
24. Harker, W. G., and Sikic, B. I. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA. Cancer Res., 45: 4091-4096, 1985.
25. Reiter, J. L., and Brodeur, G. M. High-resolution mapping of a 130-kb core region of the MYCN amplicon in neuroblastomas. Genomics, 32: 97-103, 1996.
26. Kupke, T., and Gotz, F. Expression, purification, and characterization of EpiC, an enzyme involved in the biosynthesis of the lantibiotic epidermin, and sequence analysis of Staphylococcus epidermidis epiC mutants. J. Bacteriol., 178: 1335-1340, 1996.
27. Hori, Y., Hori, H., Yamada, Y., Carrera, C. J., Tomonaga, M., Kamihira, S., Carson, D. A., and Nobori, T. The methylthioadenosine phosphorylase gene is frequently co-deleted with the pl6lNK4a gene in acute type adult T-cell leukemia. lnt.J, Cancer, 75: 51-56, 1998.